Analysis of cathepsin-K levels in biologic fluids from healthy or diseased natural teeth and dental implants

International Journal of Oral and Maxillofacial Implants

Volumn 26, Issue 5, 2011, Pages 991-997

  Yamalik, Nermin ^a   Günday, Sevim ^a   Kilinc, Kamer ^a   Karabulut, Erdem ^a   Berker, Ezel ^a   Tözüm, Tolga F ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cathepsin k; Dental implants; Gingival crevicular fluid; Natural teeth; Peri implant sulcus fluid

Indexed keywords

CATHEPSIN K;

ADULT; AGED; ALVEOLAR BONE LOSS; ARTICLE; CLASSIFICATION; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; GINGIVA; GINGIVA BLEEDING; GINGIVITIS; HUMAN; MALE; MIDDLE AGED; PERIIMPLANTITIS; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PERIODONTITIS; PERIODONTIUM; STOMATITIS; TOOTH IMPLANTATION; TOOTH PLAQUE;

ADULT; AGED; ALVEOLAR BONE LOSS; CATHEPSIN K; DENTAL IMPLANTS; DENTAL PLAQUE INDEX; FEMALE; GINGIVA; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; GINGIVITIS; HUMANS; MALE; MIDDLE AGED; PERI-IMPLANTITIS; PERIODONTAL DISEASES; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTITIS; PERIODONTIUM; STOMATITIS; YOUNG ADULT;

EID: 84857427518     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Liskmann S, Zilmer M, Vihalemm T, Salum O, Fischer K. Correlation of peri-implant health and myeloperoxidase levels: A cross-sectional clinical study. Clin Oral Implants Res 2004; 15: 546-552.
2. Romanelli R, Mancini S, Laschinger C, Overall CM, Sodek J, McCulloch CAG. Activation of neutrophil collagenase in periodontitis. Am Soc Microbiol 1999; 67: 2319-2326.
3. Beklen A, Tüter G, Sorsa T, et al. Gingival tissue and crevicular fluid co-operation in adult periodontitis. J Dent Res 2006; 85: 59-63.
4. Ilgenli T, Vardar-Sengul S, Gürkan A, et al. Gingival crevicular fluid matrix metalloproteinase-13 levels and molecular forms in various types of periodontal diseases. Oral Dis 2006; 12: 573-579.
5. Mäntylä P, Stenman M, Kinane D, et al. Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. J Periodontal Res 2006; 41: 503-512.
6. Pollock JJ, Andors L, Gulumoglu A. Direct measurement of hepatitis B virus antibody and antigen markers in gingival crevicular fluid. Oral Surg Oral Med Oral Pathol 1984; 57: 499-503.
7. Sano K, Nakao M, Shiba A, et al. An ultra-micro assay for proteins in biological fluids other than blood using a combination of agarose gel isoelectric focusing and silver staining. Clin Chim Acta 1984; 137: 115-122.
8. Genco RJ, Zambon JJ, Murray PA. Serum and gingival fluid antibodies as an adjunct in the diagnosis of Actinobacillus actinomicetamcomitansassociated periodontal disease. J Periodontol 1985; 56: 41-50.
9. Marcus ER, Jooste CP, Driver HS, Hatting J. The quantification of individual proteins in crevicular gingival fluid. J Periodontal Res 1985; 20: 444-449.
10. Mogi M, Otogoto J. Expression of cathepsin-K in gingival crevicular fluid of patients with periodontitis. Arch Oral Biol 2007; 52: 894-898.
11. Gendron R, Grenier D, Sorsa T, Mayrand D. Inihibition of the activities of matrix metalloproteinases 2, 8 and 9 by chlorhexidine. Clin Diagn Lab Immunol 1999; 6: 437-439.
12. Soell M, Elkaim R, Tenenbaum H. Cathepsin-C, matrix metalloproteinases and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients. J Dent Res 2002; 81: 174-178.
13. Ohba Y, Ohba T, Terai K, Moriyama K. Expression of cathepsin K mRNA during experimental tooth movement in rat as revealed by in situ hybridization. Arch Oral Biol 2000; 45: 63-69.
14. Nishimura F, Naruishi H, Naruishi K, et al. Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell diseasemediated gingival overgrowth: A study with cathepsin-L-deficient mice. Am J Pathol 2002; 161: 2047-2052.
15. Okaji M, Sakai H, Sakai E, et al. The regulation of bone resorption in tooth formation and eruption processes in mouse alveolar crest devoid of cathepsin K. J Pharmacol Sci 2003; 91: 285-294.
16. Drake FH, Dodds RA, James IE, et al. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 1996; 271: 12511-12516.
17. Li Z, Hou WS, Brömme D. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. Biochemistry 2000; 39: 529-536.
18. Dodds RA, Connor JR, Drake FH, Gowen M. Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues. Arthritis Rheum 1999; 42: 1588-1593.
19. Meffert RM. Periodontitis vs. peri-implantitis: The same disease? The same treatment ? Crit Rev Oral Biol Med 1996; 7: 278-291.
20. Apse P, Ellen RP, Overall CM, Zarb GA. Microbiota and crevicular fluid collagenase activity in the osseointegrated dental implant sulcus:A comparison of sites in edentulous and partially edentulous patients. J Periodontal Res 1989; 24: 96-105.
21. Boutros SM, Michalowicz BS, Smith QT, Aeppli DM. Crevicular fluid enzymes from endosseous dental implants and natural teeth. Int J Oral Maxillofac Implants 1996; 11: 322-330.
22. Jepsen S, Rühling A, Jepsen K, Ohlenbusch B, Albers HK. Progressive peri-implantitis. Incidence and prediction of peri-implant attachment loss. Clin Oral Implants Res 1996; 7: 133-142.
23. Plagnat D, Giannopoulou C, Carrel A, Bernard JP, Mombelli A, Belser UC. Elastase, alpha2-macroglobulin and alkaline phosphatase in crevicular fluid from implants with and without periimplantitis. Clin Oral Implants Res 2002; 13: 227-233.
24. Ruhling A, Jepsen S, Kocher T, Plagmann HC. Longitudinal evaluation of aspartate aminotransferase in the crevicular fluid of implants with bone loss and signs of progressive disease. Int J Oral Maxillofac Implants 1999; 14: 428-435.
25. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964; 22: 121-135.
26. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963; 21: 533-551.
27. Atici K, Yamalik N, Eratalay K, Etikan I. Analysis of gingival crevicular fluid intracytoplasmic enzyme activity in patients with adult periodontitis and rapidly progressive periodontitis. A longitudinal study model with periodontal treatment. J Periodontol 1998; 69: 1155-1163.
28. Deinzer R, Mossanen BS, Herforth A. Methodological considerations in the assessment of gingival crevicular fluid volume. J Clin Periodontol 2000; 27: 481-488.
29. Strbac GD, Monov G, Cei S, Kandler B, Watzek G, Gruber R. Cathepsin K levels in the crevicular fluid of dental implants: A pilot study. J Clin Periodontol 2006; 33: 302-308.
30. Tözüm TF, Günday S, Yamalık N. Evaluation of the peri-implant sulcus fluid (PISF) volume in response to peri-implant soft tissue inflammation. Int J Clin Dent 2009; 2: 195-203.
31. Garg G, Pradeep AR, Thorat MK. Effect of nonsurgical periodontal therapy on crevicular fluid levels of cathepsin K in periodontitis. Arch Oral Biol 2009; 54: 1046-1051.
32. Tözüm TF, Türkyilmaz I, Yamalik N, et al. Analysis of the possible impact of inflammation severity and early and delayed loading on nitric oxide metabolism around dental implants. Int J Oral Maxillofac Implants 2005; 20: 547-556.
33. Kaklamanos EG, Tsalikis L. A review on peri-implant crevicular fluid assays potential in monitoring and predicting peri-implant tissue responses. J Int Acad Periodontol 2002; 4: 49-59.
34. Cox JF, Zarb GA. The longitudinal clinical efficacy of osseointegrated dental implants: A 3-year report. Int J Oral Maxillofac Implants 1987; 2: 91-100.
35. Chaytor DV, Zarb GA, Schmitt A, Lewis DW. The longitudinal effectiveness of osseointegrated dental implants. The Toronto Study: Bone level changes. Int J Periodontics Restorative Dent 1991; 11: 112-125.
36. Mombelli A, Lang NP. Clinical parameters for the evaluation of dental implants. Periodontol 2000 1994; 4: 81-86.